Evidence map›Paper›PMID 24947511›Full record

ArticleThe Journal of biological chemistry2014

Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Asaf Sol, Yaniv Skvirsky, Rizan Nashef, Katya Zelentsova, Tal Burstyn-Cohen, Edna Blotnick, Andras Muhlrad, Gilad Bachrach

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antimicrobial peptides in 2014.Pharmaceuticals (Basel, Switzerland) · 2015
    Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Asaf SolInstitute of Dental Sciences, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Yaniv SkvirskyInstitute of Dental Sciences, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Rizan NashefDepartment of Oral and Maxillofacial Surgery, Hebrew University-Hadassah School of Dental Medicine and Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Katya ZelentsovaInstitute of Dental Sciences, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Tal Burstyn-CohenInstitute of Dental Sciences, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Edna BlotnickDepartment of Medical Neurobiology, Institute for Medical Research-Israel-Canada, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Andras MuhlradInstitute of Dental Sciences, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Gilad BachrachInstitute of Dental Sciences, Hebrew University of Jerusalem, Jerusalem 91120, Israel. Electronic address: giladba@ekmd.huji.ac.il.
Hebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Host defense peptides play an important host-protective role by their microcidal action, immunomodulatory functions, and tissue repair activities. Proteolysis is a common strategy of pathogens used to neutralize host defense peptides. Here, we show that actin, the most abundant structural protein in eukaryotes, binds the LL-37 host defense peptide, protects it from degradation by the proteases of Pseudomonas aeruginosa and Porphyromonas gingivalis, and enables its antimicrobial activity despite the presence of the proteases. Co-localization of LL-37 with extracellular actin was observed in necrotized regions of samples from oral lesions. Competition assays, cross-linking experiments, limited proteolysis, and mass spectrometry revealed that LL-37 binds by specific hydrophobic interactions to the His-40-Lys-50 segment of actin, located in the DNase I binding loop. The integrity of the binding site of both LL-37 and actin is a prerequisite to the binding. Our results demonstrate that actin, presumably released by dead cells and abundant in infected sites, might be utilized by the immune system to enhance spatio-temporal immunity in an attempt to arrest infection and control inflammation.

Indexed as

ActinsAntimicrobial Cationic PeptidesBacterial ProteinsPeptide HydrolasesBacteroidaceae InfectionsCathelicidinsFemaleHumansMalePorphyromonas gingivalisProtein Structure, SecondaryProteolysisPseudomonas aeruginosaPseudomonas InfectionsActinsAntimicrobial Cationic PeptidesBacterial ProteinsCathelicidinsPeptide HydrolasesActinAntimicrobial Peptide (AMP)Host DefenseProteaseTransglutaminase

Identifiers

PMID24947511
PMCPMC4132794
OpenAlexW2028299532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.